May 3, 2011 – Theracos, Inc., a privately held biotechnology company, announced today that it has relocated the company’s offices from Sunnyvale, California to Marlborough, Massachusetts.
Theracos, Inc., a privately held pharmaceutical research and development company, develops, acquires, and supports research programs in inflammation, metabolism, and depression through research activities throughout the world. Theracos establishes the clinical efficacy of its therapeutic candidates through multicenter international trials closely managed by a senior team of investigators.
Dr. Albert Collinson, Theracos President and CEO, indicated that the California offices were closed effective May 1, 2011. The Company’s new offices are located at 225 Cedar Hill Rd, Suite 200, Marlborough, MA.
This story originally appeared here